Veterinary Medicines

AMPIMAST syringae intramammariae 10 g

Authorised
  • Ampicillin sodium
  • Oxacillin sodium
Download as PDF

Product identification

Medicine name:
АМПИМАСТ шприц - канюли 10 g
AMPIMAST syringae intramammariae 10 g
Active substance:
  • Ampicillin sodium
  • Oxacillin sodium
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Ampicillin sodium
    300000.00
    international unit(s)
    /
    10.00
    gram(s)
  • Oxacillin sodium
    155000.00
    international unit(s)
    /
    10.00
    gram(s)
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        72
        hour
    • Sheep
      • Meat and offal
        7
        day
    • Goat
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AG04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetprom AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetprom AD
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-2322-25.06.2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 31/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."